[{"NetIncomeLoss_1_Q3_USD":-74348000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":307000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"DepreciationAndAmortization_1_Q3_USD":2200000.0,"DepreciationAndAmortization_3_Q3_USD":6175000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":48259000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":14829000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":70170000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":81176000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-93000.0,"RestrictedCashCurrent_0_Q3_USD":194000.0,"InterestPaidNet_3_Q3_USD":50000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":279192000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":527000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-83836000.0,"AssetsCurrent_0_Q3_USD":339432000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":11316174.0,"IncomeTaxesPaidNet_3_Q3_USD":7000.0,"CommonStockSharesIssued_0_Q3_shares":77220000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":326848000.0,"Assets_0_Q3_USD":405532000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-283000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":1104000.0,"Liabilities_0_Q3_USD":51597000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1396674000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":59877000.0,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_3_Q3_USD":199268000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":289000.0,"ProceedsFromStockPlans_3_Q3_USD":3407000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":2049000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":364000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":7000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":6000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-458000.0,"CommonStockValue_0_Q3_USD":8000.0,"ShareBasedCompensation_3_Q3_USD":39847000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q3_USD":44749000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q3_USD":281771000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":248778000.0,"RestrictedCash_0_Q3_USD":1400000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q3_USD":126000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-225006000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-74631000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-2718000.0,"OtherAssetsNoncurrent_0_Q3_USD":877000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":62620000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":13129000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":2004000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":12069000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":17505050.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1043274000.0,"CommonStockSharesOutstanding_0_Q3_shares":77220000.0,"RestrictedCashNoncurrent_0_Q3_USD":1200000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":17617000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-225306000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-74342000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":1521000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":13255000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-176639000.0,"AccretionExpense_3_Q3_USD":58000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":282099000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-11697000.0,"AccountsPayableCurrent_0_Q3_USD":5190000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":64014000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":12053000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":209000.0,"InterestReceivable_0_Q3_USD":800000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":230000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-165000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":51954000.0,"NetIncomeLoss_3_Q3_USD":-225313000.0,"LiabilitiesCurrent_0_Q3_USD":36055000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":179096000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":3912000.0,"OtherLiabilitiesCurrent_0_Q3_USD":5272000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":58045000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":-459000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q3_USD":44550000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-717000.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"OperatingIncomeLoss_3_Q3_USD":-227355000.0,"OperatingIncomeLoss_1_Q3_USD":-74706000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0_Q3_USD":326321000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":405532000.0,"StockholdersEquity_0_Q3_USD":353935000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":16710000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":39847000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":13255000.0,"CapitalUnitsAuthorized_0_Q3_shares":520000000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":69571000.0,"OperatingExpenses_3_Q3_USD":227355000.0,"OperatingExpenses_1_Q3_USD":74706000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-3.21,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.92,"ProfitLoss_3_Q3_USD":-225313000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2413000.0,"PreferredStockSharesAuthorized_0_Q3_shares":20000000.0,"ShortTermInvestments_0_Q3_USD":264565000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]